Option Care Health (NASDAQ:OPCH) Given New $38.00 Price Target at Barrington Research

Option Care Health (NASDAQ:OPCH) had its target price upped by Barrington Research from $33.00 to $38.00 in a research note issued on Thursday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Barrington Research’s price objective points to a potential upside of 14.63% from the company’s current price.

Several other equities analysts have also commented on OPCH. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. JPMorgan Chase & Co. increased their price target on shares of Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. UBS Group started coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price on the stock. Finally, The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $32.88.

Option Care Health Stock Performance

Shares of Option Care Health stock opened at $33.15 on Thursday. The firm has a market capitalization of $5.64 billion, a P/E ratio of 27.86, a P/E/G ratio of 2.30 and a beta of 1.35. Option Care Health has a 52 week low of $21.39 and a 52 week high of $34.17. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm’s 50 day moving average is $28.28 and its two-hundred day moving average is $28.04.

Institutional Investors Weigh In On Option Care Health

Hedge funds have recently modified their holdings of the stock. Murphy & Mullick Capital Management Corp acquired a new stake in shares of Option Care Health during the fourth quarter worth $26,000. UMB Bank n.a. lifted its holdings in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after purchasing an additional 346 shares during the period. Signaturefd LLC lifted its holdings in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after purchasing an additional 1,005 shares during the period. Quadrant Capital Group LLC lifted its holdings in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock worth $40,000 after purchasing an additional 1,099 shares during the period. Finally, Public Employees Retirement System of Ohio lifted its holdings in shares of Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after purchasing an additional 332 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.